Uncategorized

Allegro Ophthalmics Announces New Scientific Data to Be Presented During the 2021 ARVO Annual Meeting

by Business Wire • 2021/04/27 • 0 Comments

SAN JUAN CAPISTRANO, Calif.--(BUSINESS WIRE)-- #ARVO2021--Allegro Ophthalmics will present four scientific posters on risuteganib, its lead investigational compound in retina, during the 2021 ARVO Meeting.

Full Story →

← Biomarck’s MARCKS Inhibitors for Uveitis to be Presented at the 2021 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)

Reproxalap meets endpoints in phase 3 allergic conjunctivitis trial →

Post navigation